Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OptimizeBP
NCT05047731Completed
- Sponsor
- University of Alberta
- Start
- Sep 2021
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by University of Alberta. Primary endpoint: All-Cause Mortality at 4 years. Started Sep 2021; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05047731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05047731.